Ahmed Alboji

Suggest Changes
Learn More
BACKGROUND Effective inhibition of platelet aggregation during PCI in high risk patients with ACS is of utmost importance. The new intravenous short acting P2Y12-receptor inhibitor cangrelor is(More)
  • 1